Historical record - last NADAC effective date: 5/22/2024
Product Information
DOXEPIN 100 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.2992 per EA under NDC 69315016201. Its NADAC has been published 54 times since May 24, 2023.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211619FDA Approved
3/9/2021
TE Code
AB
On Market Since
4/15/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 100 MG CAPSULE has been published 54 times since May 24, 2023, and over the history we have for it it has declined 27.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2992 per EA |
|---|---|
| All-time high | $0.4473 (Aug 16, 2023) |
| All-time low | $0.2992 (May 22, 2024) |
| Median price | $0.3592 |
| Average price | $0.3703 |
| Largest weekly change | +26.6% (Nov 22, 2023) |
| Weeks tracked | 54 |
| Tracking since | May 24, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-33.1%
5Y
N/A
All
-27.4%
Last surveyed May 29, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 100 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.2992 per EA (NDC 69315016201), effective May 29, 2024.
How has the price of DOXEPIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 100 MG CAPSULE has declined 27.4%. It has been tracked across 54 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN 100 MG CAPSULE?
Since May 24, 2023, the NADAC for DOXEPIN 100 MG CAPSULE has ranged from a low of $0.2992 (May 22, 2024) to a high of $0.4473 (Aug 16, 2023), with a median of $0.3592 per EA.
Are there cheaper alternatives to DOXEPIN 100 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 100 MG CAPSULE, is $0.2669 per EA — about 11% below DOXEPIN 100 MG CAPSULE.
Who manufactures DOXEPIN 100 MG CAPSULE?
DOXEPIN 100 MG CAPSULE (NDC 69315016201) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.